New synthetic opioid cychlorphine linked to at least 55 U.S. deaths
The unregulated drug is reportedly up to 10 times more potent than fentanyl and may not be detected by standard test strips.

The drug is reportedly up to 10 times more potent than fentanyl.
Tennessee was an early hotspot for the substance. The state's health department announced in March that more than 30 fatal overdoses had been associated with cychlorphine since October 2025. An April 2026 notice from the White House’s Office of National Drug Control Policy cited at least 41 Tennessee deaths between July 2025 and February 2026 and at least 55 deaths nationally.
Fatal overdoses have also been reported in Illinois, California and Oklahoma. Cychlorphine is not approved for medical use and has been detected in illicit drugs and counterfeit pills. It can be taken as a pill, snorted in powder form, or administered intravenously.
Nicholas Kardaras, Ph.D., CEO and chief clinical officer of the New York Center for Living, called the drug "the new fentanyl on steroids." He noted that cychlorphine is one of the most potent synthetic opioids appearing in the illicit drug supply.
The drug presents several risks, including the fact that standard fentanyl test strips and routine hospital opioid urine screens do not detect it. While naloxone can reverse the effects of cychlorphine, multiple or prolonged doses may be required. The DEA advises people to administer naloxone immediately, call 911 and be prepared to give additional doses.
Key facts
- Cychlorphine is reportedly up to 10 times more potent than fentanyl.
- At least 55 deaths nationally have been linked to the drug.
- Standard fentanyl test strips and routine hospital opioid urine screens do not detect cychlorphine.
Three perspectives
Neutral
Cychlorphine is an unregulated synthetic opioid that activates the same receptors as fentanyl.
Positive
Naloxone can reverse the opioid effects of cychlorphine, though multiple doses may be necessary.
Negative
The drug is extremely potent and may not be detected by standard drug testing methods.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.